EJCTS Click here to go to Siemens website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Novitzky, D.
Right arrow Articles by Swanepoel, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Novitzky, D.
Right arrow Articles by Swanepoel, A.

European Journal of Cardio-Thoracic Surgery, Vol 3, 140-145, Copyright © 1989 by European Association for Cardio-thoracic Surgery


ARTICLES

Inotropic effect of triiodothyronine (T3) in low cardiac output following cardioplegic arrest and cardiopulmonary bypass: an initial experience in patients undergoing open heart surgery

D Novitzky, DK Cooper and A Swanepoel
Department of Cardiothoracic Surgery, University of Cape Town Medical School, Republic of South Africa.

A significant reduction in plasma free triiodothyronine (T3) (P less than 0.0001) has been observed in patients undergoing open heart surgery. The beneficial effect of T3 would appear to be associated with increased synthesis and utilization of myocardial high energy stores. We have therefore administered T3 (4-10 micrograms iv) to 10 patients either when difficulty was being experienced in weaning from cardiopulmonary bypass (CPB) support (n = 5), or when myocardial function remained extremely poor (n = 5), despite inotropic and intraaortic balloon pump support. Mean preoperative NYHA functional class of the 10 patients was 3.2, left ventricular enddiastolic pressure (LVEDP) 20 mm Hg and ejection fraction (EF) 40%. The mean myocardial ischaemia time was 72 min (range 40-120 min). Within 1 h of T3 administration the mean plasma free T3 level had risen from 1.03 to 3.56 micrograms/ml and CPB was discontinued in all 5 cases. Balloon pump support (n = 2) was no longer essential within 3 h. At 1 h, the mean arterial pressure (MAP) had risen from 42 to 78 mm Hg, and heart rate (HR) from 90 to 104 beats/min; the left atrial pressure (LAP) had fallen from 30 to 14 mm Hg, and the central venous pressure (CVP) from 20 to 11 cm H2O. (All changes significant at P less than 0.0001.) Inotropic support had been significantly reduced or discontinued. To our knowledge, T3 has not been administered previously as an inotropic agent to patients who have undergone cardiac surgery. We believe that T3 may have an important role in the rescue of failing hearts following a period of myocardial ischaemia in patients who have undergone open heart surgery.


This article has been cited by other articles:


Home page
ICVTSHome page
A. Ronald and J. Dunning
Does perioperative thyroxine have a role during adult cardiac surgery?
Interactive CardioVascular and Thoracic Surgery, April 1, 2006; 5(2): 166 - 178.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
R. Salenger, J. S. Gammie, and T. J. Vander Salm
Postoperative Care of Cardiac Surgical Patients
Card. Surg. Adult, January 1, 2003; 2(2003): 439 - 469.
[Full Text]


Home page
Arch SurgHome page
A. Salim, P. Vassiliu, G. C. Velmahos, J. Sava, J. A. Murray, H. Belzberg, J. A. Asensio, and D. Demetriades
The Role of Thyroid Hormone Administration in Potential Organ Donors
Arch Surg, December 1, 2001; 136(12): 1377 - 1380.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. D. Mainwaring, E. Capparelli, K. Schell, M. Acosta, and J. C. Nelson
Pharmacokinetic Evaluation of Triiodothyronine Supplementation in Children After Modified Fontan Procedure
Circulation, March 28, 2000; 101(12): 1423 - 1429.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. D. Klemperer, I. Klein, M. Gomez, R. E. Helm, K. Ojamaa, S. J. Thomas, O. W. Isom, and K. Krieger
Thyroid Hormone Treatment after Coronary-Artery Bypass Surgery
N. Engl. J. Med., December 7, 1995; 333(23): 1522 - 1527.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. G. Katz, A. J. Cohen, H. Schwalb, J. Segal, G. Merin, and A. Schachner
Interaction of Thyroid Hormone and Heparin in Postischemic Myocardial Recovery
Ann. Thorac. Surg., November 1, 1995; 60(5): 1215 - 1218.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. D. Klemperer, J. Zelano, R. E. Helm, K. Berman, K. Ojamaa, I. Klein, O. W. Isom, and K. Krieger
Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemia
J. Thorac. Cardiovasc. Surg., March 1, 1995; 109(3): 457 - 465.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1989 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.